Are you looking for support with your novel therapy?

SPRINT Project
Process Innovation for Novel Therapies
Eligibility
United Kingdom

Are you looking for support with your novel therapy?

If so, we can help you!

CPI is delivering a new ERDF Project, SPRINT (Supporting Process Innovation for Novel Therapies) across the Greater Cambridge and Greater Peterborough Region to support commercialisation of Novel therapies.

How do we make this possible?

The fully funded programme will assist SMEs active in or seeking to access the BioTech/​Life Sciences, Healthcare/​Medtech, Digital, Information Technologies/​Artificial Intelligence and Advance Manufacturing sectors.

The SPRINT project will be delivered from the existing CPI facilities within Darlington offering a large range of state-of-the-art equipment and highly skilled scientists in the Upstream, Downstream, Analytical and Formulation areas. As the project is working within the Greater Cambridge and Greater Peterborough LEP Region the project will have an office presence within Cambridge for customer engagement and innovation clinics.

Support for SME product/​process development will be offered at appropriate scales, ranging from laboratory to pilot and prototyping in order to help local SMEs develop and launch innovative new products.

CPI is an experienced partner supporting your path to commercialisation, through this ERDF funded programme, giving you access to business services, product and process development assets and expertise, as well as access to our state-of-the-art Biologics facilities.

Using CPIs expertise, the project offers

  • Business Support — Initial innovation clinics/​Workshops to provide initial advice, support, and signposting to relevant business support mechanisms 
  • Proof of concept and process development projects executed by CPI
  • Equipment — Specialist assets for the development of (bio)pharmaceutical production processes and analysis of (bio)pharmaceutical products 
  • Technical Expertise — Product development planning to develop scalable production processes that will meet GMP standards
Photo of CPI scientist

Eligibility

  • Small/​Medium sized enterprises (SMEs) with a registered address, located within the Greater Cambridge and Greater Peterborough Region (GCGP LEP)
  • Must be an SME in the BioTech/​Life Sciences, Healthcare/​Medtech, Digital, Information Technologies/​Artificial Intelligence and Advance Manufacturing sectors
  • Staff head count less than 250 
  • Annual turnover less than 50 million euros
  • Net Balance sheet less than 43 million euros 

The support offered will help companies better understand their product/​process and to overcome the challenges to taking this to scalable production. 

Let’s innovate together

Contact Us

The Internet of Things: Modernising Healthcare

Matthew Herbert

Matthew Herbert

Head of Marketing Communications

Can healthcare wearables help early detection of COVID-19?

Alex Cole

Alex Cole

Strategic Marketing Manager

Start Date: 01 Apr 2020 End Date: 31 Mar 2023